Celemics (셀레믹스)
Seoul, South Korea
Celemics is a biotech company developing Innovative NGS-based materials through novel sequencing technology to disrupt the paradigm of the medicine, biopharma, AgBio, synthetic biology, and microbiome industries. Celemics has developed the MSSIC platform to provide customized target capture probes with advanced genome analysis capabilities to accelerate drug discovery for immune profiling and antibody library sequencing purposes. As a manufacturer of hybridization captured target enrichment kits for NGS applications, Celemics secured itself as one of the frontrunners in the global genetic testing market. Celemics offers defined panels and customized target enrichment kits in the IVD and RUO sectors with remarkable synthetic probe rebalancing technologies under stringent quality management systems (ISO 9001, ISO 13485, GMP).
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2010
- Website
- www.celemics.com/?ckattempt=2
Only accessible to MedStartr community members.
Join nowWhat do you think of Celemics (셀레믹스)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now